Invasive pneumococcal disease in HIV-infected adults: Clinical changes after the introduction of the pneumococcal conjugate vaccine in children

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 1, 2012, Pages 31-38

  Burgos, Joaquin ^a   Peñaranda, Maria ^b   Payeras, Antoni ^c   Villoslada, Aroa ^c   Curran, Adrian ^a   Garau, Margarita ^c   Riera, Melcior ^b   Crespo, Manuel ^a   Navarro, Jordi ^a   Van Den Eynde, Eva ^a   Planes, Ana Maria ^a   Ribera, Esteban ^a   Pahissa, Albert ^a   Falcó, Vicenç ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c HOSPITAL SON LLÀTZER   (Spain)

Author keywords

HIV infected patients; invasive pneumococcal disease; pneumococcal conjugated vaccine; Streptococcus pneumonia

Indexed keywords

CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; VACCINATION;

ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 83655198149     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31823d0f5f     Document Type: Article

References (32)

1. Nuorti JP, Butler JC, Gelling L, et al. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco Country, California. Ann Intern Med. 2000;132:182-190. (Pubitemid 30064917)
2. Heffernan RT, Barrett NL, Gallagher KM, et al. Declining incidence of invasive streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis. 2005;191:2038-2045. (Pubitemid 40800574)
3. Grau I, Pallares R, Tubau F, et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med. 2005; 165:1533-1540. (Pubitemid 41058035)
4. Curran A, Falcó V, Crespo M, et al. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med. 2008;9: 609-615.
5. Jordano Q, Falcó V, Almirante B, et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis. 2004;38:1623-1628. (Pubitemid 38738561)
6. Grau I, Ardanuy C, Liñares J, et al. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease. HIV Med. 2009;10:488-495.
7. Singleton R, Hennessy T, Bulkow L, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children high levels of 7-Valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784-1792. (Pubitemid 46658647)
8. Jacobs MR, Good CE, Bajaksouzian S, et al. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis. 2008;47:1388-1395.
9. Ardanuy C, Tubau F, Pallares R, et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis. 2009;48:57-64.
10. Kellner JD, Vanderkooi OG, MacDonald J, et al. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis. 2009;49:205-212.
11. Tsigrelis C, Tleyjeh IM, Lahr BD, et al. Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota. J Infect Dis. 2009;59:188-193.
12. Rosen JB, Thomas AR, Lexau CA, et al. Geographic variation in Invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis. 2011;53:137-143.
13. Byington CL, Samore MH, Stoddard GJ, et al. Temporal Trends of Invasive Disease Due to Streptococcus pneumoniae among Children in the Intermountain West: Emergence of Nonvaccine Serogroups. Clin Infect Dis. 2005;41:21-29. (Pubitemid 40863739)
14. Bender JM, Ampofo K, Korgenski K, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis. 2008;46: 1346-1352. (Pubitemid 351589931)
15. Payeras A, Villoslada A, Garau M, et al. Pneumococcal pneumonia in the era of heptavalent pneumococcal conjugate vaccine. Enferm Infecc Microbiol Clin. 2011;29:250-256.
16. Burgos J, Lujan M, Falcó V, et al. The spectrum of pneumococcal empyema in adults in the early 21st Century. Clin Infect Dis. 2011;53:254-261.
17. Enfermedad invasiva por Streptococcus pneumoniae. Implicación de la vacunación con la vacuna conjugada heptavalente.Madrid: Ministerio de Sanidad y Consumo. 2006. Available at: http://www.msc.es/ciudadanos/ proteccionSalud/infancia/vacunaciones/home.htm. Accessed June 2011.
18. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41: 1-19.
19. Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304:321-333.
20. Panel de expertos de Gesida y Plan Nacional sobre el Sida. National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update). Enferm Infecc Microbiol Clin. 2011;29:209.e1-103.
21. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-MS18. Wayne, PA: CLSI; 2008.
22. Peñaranda M, Falco V, Payeras A, et al. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Clin Infect Dis. 2007;45:82-87.
23. Rodriguez-Barradas M, Goulet J, Brown S, et al. Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection statis among patients enrolled in the veterans aging cohort 5-site study. Clin Infect Dis. 2008;46:1093-1100. (Pubitemid 351589878)
24. Pedersen RH, Lohse N, Østergaard L, et al. The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review. HIV Med. 2011;12:323-343.
25. Flannery B, Hefferman RT, Harrison LH, et al. Changes in invasive pneumococcal disease among HIV-Infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med. 2006;144:1-9. (Pubitemid 46780714)
26. Cohen AL, Harrison LH, Farley MM, et al. Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS. 2010;24:2253-3362.
27. Kuortis A, Ellington S, Bansil P, et al. Hospitalizations for invasive pneumococcal disease among HIV-1-infected adolescents and adults in the United States in the era of highly active antiretroviral therapy and the conjugate pneumococcal vaccine. J Acquir Immune Defic Syndr. 2010;55:128-131.
28. Janoff EN, O'Brien J, Thompson P, et al. Streptococcus pneumonia colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis. 1993;167:49-56. (Pubitemid 23002836)
29. Imaz A, Falcó V, Peñaranda A, et al. Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease. HIV Med. 2009;10:356-363.
30. Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294:2043-2051. (Pubitemid 41539937)
31. Calbo E, Díaz A, Cañadell E, et al. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect. 2006;12:867-872. (Pubitemid 44151286)
32. Sanz JC, Cercenado E, Marín M, et al. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients. Clin Microbiol Infect. 2011;17:1094-1098.